5 Multiple Myeloma Clinical Trials in Grand Rapids, MI (2026)

Q: How do I join a clinical trial in Grand Rapids?

Browse available studies, click one that interests you, and complete the free eligibility form. A study coordinator at the Grand Rapids research site will contact you.

Recruiting Multiple Myeloma Studies in Grand Rapids

NCT06433947Recruiting

Study to Assess Safety and Tolerability of OPN-6602 in Subjects With Relapsed and/or Refractory Multiple Myeloma

Phase 1b, open-label study evaluating the safety, tolerability, pharmacokinetics, preliminary antitumor activity, and pharmacodynamics of OPN-6602 monotherapy and in combination with dexamethasone in ...

Grand Rapids, MI130 participantsOpna Bio LLC

View Study Details

NCT07409246Recruiting

A Study to Evaluate Adverse Events, Change in Disease Activity, Tolerability, and How Intravenous ABBV-438 Moves Through the Body in Adult Participants With Multiple Myeloma (MM)

Multiple myeloma (MM) is a plasma cell disease characterized by the growth of clonal plasma cells in the bone marrow. The purpose of this study is to assess the safety, tolerability, and how ABBV-438 ...

Grand Rapids, MI127 participantsAbbVie

View Study Details

NCT05714839Recruiting

A Study to Investigate the Safety and Efficacy of Belantamab for the Treatment of Multiple Myeloma When Used as Monotherapy and in Combination Treatments

The study consists of three parts: Part 1 The primary purpose of this part aims to evaluate the safety, tolerability, and clinical activity of escalating doses of single agent Unconjugated belantamab ...

Grand Rapids, MI123 participantsGlaxoSmithKline

View Study Details

NCT07284758Recruiting

A Study to Evaluate the Efficacy of Cemsidomide + Dexamethasone in Participants With Relapsed/Refractory Multiple Myeloma

This is a Phase 2, open-label, single-arm, multicenter study to assess the antimyeloma activity and further characterize the safety, tolerability, PK, and PD of cemsidomide in combination with dexamet...

Grand Rapids, MI100 participantsC4 Therapeutics, Inc.

View Study Details

NCT07280013Recruiting

A Study to Learn About the Effects of Cemsidomide in Combination With Elranatamab in Relapsed/Refractory Multiple Myeloma Subjects

The main purpose of the study is to understand the safety and tolerability of cemsidomide when given along with elranatamab in subjects with relapsed or refractory multiple myeloma. The first part of...

Grand Rapids, MI60 participantsC4 Therapeutics, Inc.

View Study Details

About Multiple Myeloma Clinical Trials in Grand Rapids

Multiple myeloma is a cancer of plasma cells in the bone marrow that produce abnormal antibodies. It can cause bone damage, kidney problems, and immune deficiency. Treatments have advanced significantly with proteasome inhibitors, immunomodulatory drugs, and CAR-T cell therapy.

There are currently 5 multiple myeloma clinical trials recruiting participants in Grand Rapids, MI. These studies are seeking a combined 540 participants. Research is being sponsored by Opna Bio LLC, AbbVie, GlaxoSmithKline and 1 other organizations. Clinical trial participation is free and participants receive study-related medical care at no cost.

Multiple Myeloma Clinical Trials in Grand Rapids — FAQ

Are there multiple myeloma clinical trials in Grand Rapids?

Yes, there are 5 multiple myeloma clinical trials currently recruiting in Grand Rapids, MI. Browse the studies on this page to find one that fits.

How do I join a clinical trial in Grand Rapids?

Browse the studies listed above, click one that interests you, and complete the free eligibility form. A study coordinator at the Grand Rapids research site will contact you about next steps.

Are clinical trials in Grand Rapids free?

Yes, clinical trial participation is always free. Study-related treatment, medical tests, and doctor visits are provided at no cost. Many Grand Rapids studies also compensate for your time and travel.

What multiple myeloma treatments are being tested?

The 5 active trials in Grand Rapids are testing new therapies including novel drugs, biologics, and treatment approaches for multiple myeloma.

Data updated July 13, 2026 from ClinicalTrials.gov